Improving treatments for childhood cystic kidney disease
UAB Childhood Cystic Kidney Disease Core Center (UAB-CCKDCC) - Administrative Core
This study is all about finding better ways to treat cystic kidney diseases in kids by working with a team of experts to understand how certain proteins affect the disease and testing new treatments that could help slow it down.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10884921 on NIH RePORTER |
What this research studies
This research focuses on enhancing the understanding and treatment of cystic kidney diseases in children by collaborating with a consortium of experts. The team aims to eliminate barriers in research that hinder the development of innovative therapies. They will provide access to clinical data and biological materials from patients, as well as develop animal and cell models to test potential treatments. The goal is to identify how specific proteins contribute to the disease and to evaluate new therapies that could slow its progression.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with cystic kidney diseases who may benefit from new therapeutic approaches.
Not a fit: Patients with non-cystic kidney diseases or those who do not meet the specific criteria for cystic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for children suffering from cystic kidney diseases.
How similar studies have performed: Previous research has shown promise in developing treatments for cystic kidney diseases, indicating that this approach could build on existing knowledge.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Yoder, Bradley K. — University of Alabama at Birmingham
- Study coordinator: Yoder, Bradley K.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.